RTN4 and breast cancer: These results are consistent with other researchers suggesting the increased expression of Nogo-B and/or NgBR in BC on top of an inverse correlation of Nogo-B expression with survival and treatment response to tamoxifen and paclitaxel, signifying the prognostic and therapeutic potential of RTN4 in BC [22,52].